Cervical Pain
Conditions
Brief summary
A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.
Detailed description
The patients will randomly be divided into two equal groups; the control group which will receive the selected exercise program and the study group will receive the same exercise training program in addition to Chitosan Phonophresis, three times per week for four weeks.
Interventions
DRUGChitosan Phonophresis
Chitosan Phonophresis, three times per week for four weeks.
OTHERselected physical therapy exercise
selected neck exercise and electrotherapy on cervical region
Sponsors
October 6 University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
16 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Their age will be ranged from 16-18 years * body mass index will be 26.58 kg/m2. * used a smart phone for more than 1 year for at least 2 hours per day * complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)
Exclusion criteria
* any previous head and neck injuries or surgeries * any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine * any uncorrected visual or auditory problems, dizziness, vertigo and headache * any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests * body mass index of subjects over25 kg/m2.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Smartphone Addiction Scale-Short Version (SAS-SV) | four weeks | SAS-SV was psychometrically robust in measuring the severity of smartphone addiction |
| The visual analogue scale | four weeks | was utilized to evaluate pre- and post-treatment neck pain |
| Neck disability index | four weeks | assess how neck pain and other symptoms manifested during various functional activities. Ndi had been reported as a reliable (Cronbach's alpha: 0.89) and valid instrument to evaluate self-rated disability in patients with neck pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cervical ROM | four weeks | Cervical active ROM will be measured for each participant in the study by digital goniometer device. |
Countries
Egypt
Contacts
Primary ContactLama Saad El-Din ED Mahmoud
Outcome results
None listed